Delivery Order SPE2DB22D2103-SPE2DB24FR9AL
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,052.00 and a performance period through March 12, 2024. This award is a part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for 4,565,265,315 units of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The order has a ceiling value of $2,054.50 and a completion date of July 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,052.00 to the prime contractor, AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order in the amount of $3,156.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the procurement of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This delivery order, which has a completion date of January 31, 2024, is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a...
- The U.S. government awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML medication. The contract, valued at $19,072.21, has an ultimate completion date of July 1, 2025 and was awarded on June 30, 2025 by the Defense Logistics Agency (DLA), a defense agency. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order, valued at $1,052.00, has a completion date of March 1, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $16,257.11 and a period of performance through May 23, 2024. The award is for the supply of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The $1,434.71 contract has a completion date of February 1, 2024 and was awarded on January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,596,804 units of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of February 9, 2024 and a potential value of $1,578.00. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $11,445.72 and a period of performance through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB24FR9ALDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,934,470 units of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $3,125.49 and a completion date of March 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 3/12/24 |